Successful Treatment of a 74-year-old man with Refractory Anemia with Excess of Blasts in Transformation(RAEB in T) by Low-Dose Ara-C Injection.

Abnormal Erythroid Cell Proliferation and Myelofibrosis in a Cat

“…Plasma thymidine kinase activity was high (636 IU/l) compared with clinically healthy control cats (<5 IU/l: n=22) 46 days after the 1st examination, indicating a myeloproliferative condition, as shown in other species [4,5,8]. The cat was regarded as having an MDS-like condition and was treated with low-dose cytarabine (20 mg/m 2 q24h subcutaneously) with reference to treatment for human MDS patients [7,13]. The cat's hemogram improved after starting cytarabine therapy as evidenced by decreasing numbers of prorubricytes and basophilic rubricytes and an increasing number of late-stage erythroid cells (Fig.…”